Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense - PubMed (original) (raw)
Review
. 2000 May 3;283(17):2281-90.
doi: 10.1001/jama.283.17.2281.
D T Dennis, D A Henderson, J G Bartlett, M S Ascher, E Eitzen, A D Fine, A M Friedlander, J Hauer, J F Koerner, M Layton, J McDade, M T Osterholm, T O'Toole, G Parker, T M Perl, P K Russell, M Schoch-Spana, K Tonat
Affiliations
- PMID: 10807389
- DOI: 10.1001/jama.283.17.2281
Review
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense
T V Inglesby et al. JAMA. 2000.
Abstract
Objective: The Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals following the use of plague as a biological weapon against a civilian population.
Participants: The working group included 25 representatives from major academic medical centers and research, government, military, public health, and emergency management institutions and agencies.
Evidence: MEDLINE databases were searched from January 1966 to June 1998 for the Medical Subject Headings plague, Yersinia pestis, biological weapon, biological terrorism, biological warfare, and biowarfare. Review of the bibliographies of the references identified by this search led to subsequent identification of relevant references published prior to 1966. In addition, participants identified other unpublished references and sources. Additional MEDLINE searches were conducted through January 2000.
Consensus process: The first draft of the consensus statement was a synthesis of information obtained in the formal evidence-gathering process. The working group was convened to review drafts of the document in October 1998 and May 1999. The final statement incorporates all relevant evidence obtained by the literature search in conjunction with final consensus recommendations supported by all working group members.
Conclusions: An aerosolized plague weapon could cause fever, cough, chest pain, and hemoptysis with signs consistent with severe pneumonia 1 to 6 days after exposure. Rapid evolution of disease would occur in the 2 to 4 days after symptom onset and would lead to septic shock with high mortality without early treatment. Early treatment and prophylaxis with streptomycin or gentamicin or the tetracycline or fluoroquinolone classes of antimicrobials would be advised.
Comment in
- Safety precautions to limit exposure from plague-infected patients.
Nolte KB. Nolte KB. JAMA. 2000 Oct 4;284(13):1648; author reply 1649. JAMA. 2000. PMID: 11015787 No abstract available. - Safety precautions to limit exposure from plague-infected patients.
Levison ME. Levison ME. JAMA. 2000 Oct 4;284(13):1648-9. JAMA. 2000. PMID: 11015788 No abstract available.
Similar articles
- Tularemia as a biological weapon: medical and public health management.
Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, Lillibridge SR, McDade JE, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Tonat K; Working Group on Civilian Biodefense. Dennis DT, et al. JAMA. 2001 Jun 6;285(21):2763-73. doi: 10.1001/jama.285.21.2763. JAMA. 2001. PMID: 11386933 Review. - Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Hauer J, McDade J, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Tonat K. Inglesby TV, et al. JAMA. 1999 May 12;281(18):1735-45. doi: 10.1001/jama.281.18.1735. JAMA. 1999. PMID: 10328075 Review. - Botulinum toxin as a biological weapon: medical and public health management.
Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K; Working Group on Civilian Biodefense. Arnon SS, et al. JAMA. 2001 Feb 28;285(8):1059-70. doi: 10.1001/jama.285.8.1059. JAMA. 2001. PMID: 11209178 Review. - Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, Hauer J, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl T, Russell PK, Tonat K. Henderson DA, et al. JAMA. 1999 Jun 9;281(22):2127-37. doi: 10.1001/jama.281.22.2127. JAMA. 1999. PMID: 10367824 Review. - Anthrax as a biological weapon, 2002: updated recommendations for management.
Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J, McDade J, Osterholm MT, Parker G, Perl TM, Russell PK, Tonat K; Working Group on Civilian Biodefense. Inglesby TV, et al. JAMA. 2002 May 1;287(17):2236-52. doi: 10.1001/jama.287.17.2236. JAMA. 2002. PMID: 11980524 Review.
Cited by
- Characterization of systemic and pneumonic murine models of plague infection using a conditionally virulent strain.
Mellado-Sanchez G, Ramirez K, Drachenberg CB, Diaz-McNair J, Rodriguez AL, Galen JE, Nataro JP, Pasetti MF. Mellado-Sanchez G, et al. Comp Immunol Microbiol Infect Dis. 2013 Mar;36(2):113-28. doi: 10.1016/j.cimid.2012.10.005. Epub 2012 Nov 26. Comp Immunol Microbiol Infect Dis. 2013. PMID: 23195858 Free PMC article. - Deliberate release: Plague - A review.
Ansari I, Grier G, Byers M. Ansari I, et al. J Biosaf Biosecur. 2020 Mar;2(1):10-22. doi: 10.1016/j.jobb.2020.02.001. Epub 2020 Mar 30. J Biosaf Biosecur. 2020. PMID: 32835180 Free PMC article. Review. - Thirty-Two Complete Genome Assemblies of Nine Yersinia Species, Including Y. pestis, Y. pseudotuberculosis, and Y. enterocolitica.
Johnson SL, Daligault HE, Davenport KW, Jaissle J, Frey KG, Ladner JT, Broomall SM, Bishop-Lilly KA, Bruce DC, Coyne SR, Gibbons HS, Lo CC, Munk AC, Rosenzweig CN, Koroleva GI, Palacios GF, Redden CL, Xu Y, Minogue TD, Chain PS. Johnson SL, et al. Genome Announc. 2015 Apr 30;3(2):e00148-15. doi: 10.1128/genomeA.00148-15. Genome Announc. 2015. PMID: 25931590 Free PMC article. - Bioterrorism: An Emerging Public Health Problem.
Cariappa MP, Vaz LS, Sehgal P. Cariappa MP, et al. Med J Armed Forces India. 2002 Oct;58(4):325-30. doi: 10.1016/S0377-1237(02)80089-2. Epub 2011 Jul 21. Med J Armed Forces India. 2002. PMID: 27407424 Free PMC article. No abstract available. - Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor.
Do Y, Didierlaurent AM, Ryu S, Koh H, Park CG, Park S, Perlin DS, Powell BS, Steinman RM. Do Y, et al. Vaccine. 2012 Oct 5;30(45):6359-67. doi: 10.1016/j.vaccine.2012.08.051. Epub 2012 Sep 1. Vaccine. 2012. PMID: 22947140 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical